177 related articles for article (PubMed ID: 22174819)
1. Antitumor activity of a novel oncrasin analogue is mediated by JNK activation and STAT3 inhibition.
Guo W; Wu S; Wang L; Wei X; Liu X; Wang J; Lu Z; Hollingshead M; Fang B
PLoS One; 2011; 6(12):e28487. PubMed ID: 22174819
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic effect of flavonoids on NSC-741909-mediated antitumor activity via scavenging of reactive oxygen species.
Guo W; Wei X; Wu S; Wang L; Peng H; Wang J; Fang B
Eur J Pharmacol; 2010 Dec; 649(1-3):51-8. PubMed ID: 20854805
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in NSC-741909-induced apoptosis of cancer cells.
Wei X; Guo W; Wu S; Wang L; Huang P; Liu J; Fang B
J Transl Med; 2010 Apr; 8():37. PubMed ID: 20398386
[TBL] [Abstract][Full Text] [Related]
4. Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380.
Wu S; Wang L; Huang X; Cao M; Hu J; Li H; Zhang H; Sun X; Meng QH; Hofstetter WL; Roth JA; Swisher SG; Fang B
Bioorg Med Chem; 2014 Oct; 22(19):5234-40. PubMed ID: 25182964
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting JNK dephosphorylation and induction of apoptosis by novel anticancer agent NSC-741909 in cancer cells.
Wei X; Guo W; Wu S; Wang L; Lu Y; Xu B; Liu J; Fang B
J Biol Chem; 2009 Jun; 284(25):16948-16955. PubMed ID: 19414586
[TBL] [Abstract][Full Text] [Related]
6. Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis.
Gupta P; Dixit D; Sen E
Carcinogenesis; 2013 Feb; 34(2):388-96. PubMed ID: 23125226
[TBL] [Abstract][Full Text] [Related]
7. Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells.
Wu WS; Chien CC; Chen YC; Chiu WT
PLoS One; 2016; 11(8):e0160484. PubMed ID: 27483435
[TBL] [Abstract][Full Text] [Related]
8. Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota.
Guo W; Wu S; Liu J; Fang B
Cancer Res; 2008 Sep; 68(18):7403-8. PubMed ID: 18794128
[TBL] [Abstract][Full Text] [Related]
9. Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities.
Wu S; Wang L; Guo W; Liu X; Liu J; Wei X; Fang B
J Med Chem; 2011 Apr; 54(8):2668-79. PubMed ID: 21443218
[TBL] [Abstract][Full Text] [Related]
10. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
[TBL] [Abstract][Full Text] [Related]
11. A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling.
Liu L; Kritsanida M; Magiatis P; Gaboriaud N; Wang Y; Wu J; Buettner R; Yang F; Nam S; Skaltsounis L; Jove R
Cancer Biol Ther; 2012 Nov; 13(13):1255-61. PubMed ID: 22895078
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells.
Liu X; Guo W; Wu S; Wang L; Wang J; Dai B; Kim ES; Heymach JV; Wang M; Girard L; Minna J; Roth JA; Swisher SG; Fang B
Biochem Pharmacol; 2012 May; 83(10):1456-64. PubMed ID: 22387047
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo.
Kandala PK; Srivastava SK
Drug Discov Ther; 2012 Apr; 6(2):94-101. PubMed ID: 22622019
[TBL] [Abstract][Full Text] [Related]
15. A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation.
Kim D; Sun M; He L; Zhou QH; Chen J; Sun XM; Bepler G; Sebti SM; Cheng JQ
J Biol Chem; 2010 Mar; 285(11):8383-94. PubMed ID: 20068047
[TBL] [Abstract][Full Text] [Related]
16. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
[TBL] [Abstract][Full Text] [Related]
17. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
Lin L; Hutzen B; Li PK; Ball S; Zuo M; DeAngelis S; Foust E; Sobo M; Friedman L; Bhasin D; Cen L; Li C; Lin J
Neoplasia; 2010 Jan; 12(1):39-50. PubMed ID: 20072652
[TBL] [Abstract][Full Text] [Related]
18. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.
Lei P; Abdelrahim M; Cho SD; Liu S; Chintharlapalli S; Safe S
Carcinogenesis; 2008 Jun; 29(6):1139-47. PubMed ID: 18460448
[TBL] [Abstract][Full Text] [Related]
19. Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1).
Guo W; Wu S; Wang L; Wang RY; Wei X; Liu J; Fang B
Mol Cancer Ther; 2009 Feb; 8(2):441-8. PubMed ID: 19208825
[TBL] [Abstract][Full Text] [Related]
20. 6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.
Liu L; Nam S; Tian Y; Yang F; Wu J; Wang Y; Scuto A; Polychronopoulos P; Magiatis P; Skaltsounis L; Jove R
Cancer Res; 2011 Jun; 71(11):3972-9. PubMed ID: 21610112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
